Our Metastasis On-A-Chip (MoC) device offers an in vitro model for non-clinical trial alternative for precision medicine. The captured patient cells from the microchip undergoes single cell sequencing to study the genetic signature of metastatic cells for personalised cancer treatment recommendations.

We revolutionise cancer research and treatment by providing a non-invasive, less expensive and more efficient alternative to clinical trials. 

Learn more below: